FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Instagram Outage Disrupts Thousands of U.S. Users 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
SAN FRANCISCO, April 17, 2017 -- Hagens Berman Sobol Shapiro LLP reminds investors in Chicago Bridge & Iron Company N.V. (NYSE:CBI) of the May 1, 2017 Lead Plaintiff deadline in the pending securities class action.
If you purchased or otherwise acquired securities of CBI between October 29, 2013 and December 10, 2014 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/CBI
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing [email protected].
The securities class action concerns the Company’s February 2013 acquisition of - and related accounting for - a business known as The Shaw Group. When CBI purchased Shaw, CBI acquired purportedly high-value contracts to complete construction of new nuclear power plants including Plant Vogtle.
On June 17, 2014, Prescience Point issued a report entitled “Acquisition Accounting Gone Nuclear” concluding that Defendants misstated the Company’s previously reported balance sheet, income from operations and earnings per share through inappropriate acquisition accounting for Shaw. This news drove the price of CBI shares down over 8% to close at $68.26 that day.
On December 10, 2014, TradeFair Group reported that longer delays are likely for the Vogtle reactors. Between December 7, 2014 and December 12, 2014, as the market digested this information, the price of CBI’s shares fell almost 15% to close at $39.14 on December 12.
“We’re focused on what may be serious violations of generally accepted accounting principles in connection with the Company’s business combination with Shaw that, if true, had a material impact on CBI’s financial condition,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding CBI should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000
